Physician profile
Linqiu Zhou
NPI 1932128717
$2,922.20
in general payments reported to CMS, 2019-2025
18 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $301 · 2021: $78.73 · 2022: $188 · 2023: $1,360 · 2024: $229 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,204 · Travel and Lodging: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,203.64 |
| Travel and Lodging | $757.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $928.37 | 2023 | Iovera, Exparel, Zilretta |
| Boston Scientific Corporation | $817.29 | 2020-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic USA, INC. | $356.61 | 2019-2020 | |
| Nevro Corp. | $211.80 | 2020-2024 | Senza |
| Gilead Sciences, INC. | $125.00 | 2023 | Vemlidy |
| Medtronic, INC. | $106.71 | 2021-2025 | Accurian |
| Saluda Medical Americas, INC. | $58.05 | 2023 | Evoke Scs |
| Vertos Medical, INC. | $57.55 | 2022-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $53.51 | 2024-2025 | Prospera |
| Abbott Laboratories | $38.79 | 2019-2023 | Proclaim |
| Protega Pharmaceutials INC | $30.80 | 2024 | Roxybond |
| Kowa Pharmaceuticals America, INC. | $29.69 | 2023 | Seglentis |
| Ibsa Pharma INC. | $24.98 | 2021 | |
| Merz Pharmaceuticals, LLC | $21.08 | 2023 | Xeomin |
| Spr Therapeutics, INC | $18.15 | 2024 | Sprint Pns System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.96 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.58 | 2019 | |
| Si-Bone, INC. | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linqiu Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.